Home

Riad Hussein El-Dada

CIK 1926018 · last filed 2026-06-26

Riad Hussein El-Dada is a corporate insider who has filed 10 SEC Form 4 insider transactions across 3 companies since 2022. The most recent filing shows the insider sold $40.5K of KLTO on Jun 26, 2026. Across all open-market trades the lifetime net is −$40.5K, making them a net seller over the disclosed history.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

3

Total Filings

10

Lifetime Open-Market Net

-$40.5K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
Klotho Neurosciences, Inc. (KLTO) Delisted Director 175,000 $0.52 $91.7K -$40.5K 1 2026-06-26
Klotho Neurosciences, Inc. (KLTOW) Delisted Director 350,000 $0.09 $30.1K $0 3 2026-03-06
Keenova Therapeutics plc (MNK) Delisted Director 23,122 $0.34 $7.9K $0 4 2023-06-29

Recent Filings

10 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-06-26 Klotho Neurosciences, Inc. (KLTO) Delisted Sell (S) −175,000 -$40.5K EDGAR
2026-06-24 GRML Notice (144) −175,000 -$39.9K EDGAR
2026-03-06 Klotho Neurosciences, Inc. (KLTOW) Delisted Grant (A) +350,000 $0 EDGAR
2025-12-10 Klotho Neurosciences, Inc. (KLTOW) Delisted Grant (A) — $0 EDGAR
2025-08-08 Klotho Neurosciences, Inc. (KLTOW) Delisted Grant (A) — $0 EDGAR
2023-11-16 — Disp (D) −23,122 $0
2023-06-29 Keenova Therapeutics plc (MNK) Delisted Mixed −29,431 -$4.0K EDGAR
2023-01-05 Keenova Therapeutics plc (MNK) Delisted Grant (A) +26,277 $0 EDGAR
2022-09-14 Keenova Therapeutics plc (MNK) Delisted Disp (D) — $0 EDGAR
2022-07-06 Keenova Therapeutics plc (MNK) Delisted Grant (A) — $0 EDGAR
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.